Clinical variables associated with PSA response to lutetium-177-PSMA ([177LU]-PSMA-617) radionuclide treatment in men with metastatic castration-resistant prostate cancer
Research output: Contribution to journal › Article › peer-review
20Scopus
citations
Fingerprint
Dive into the research topics of 'Clinical variables associated with PSA response to lutetium-177-PSMA ([177LU]-PSMA-617) radionuclide treatment in men with metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.